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We illustrate a case of midventricle obstructive HCM and apical aneurysm diagnosed with appropriate use of multimodality
imaging. A 75-year-old AfricanAmericanwoman presented with a 3-day history of chest pain and dyspnea with elevated troponins.
Her electrocardiogram showed sinus rhythm, left atrial enlargement, left ventricular hypertrophy, prolonged QT, and occasional
ectopy. After medical therapy optimization, she underwent coronary angiography for an initial diagnosis of non-ST segment
elevation myocardial infarction. Her coronaries were unremarkable for significant disease but her left ventriculogram showed
hyperdynamic contractility of the midportion of the ventricle along with a large dyskinetic aneurysmal apical sac. A subsequent
transthoracic echocardiogram provided poor visualization of the apical region of the ventricle but contrast enhancement identified
an aneurysmal pouch distal to themidventricular obstruction. To further clarify the diagnosis, cardiacmagnetic resonance imaging
with contrast was performed confirming the diagnosis of midventricular hypertrophic cardiomyopathy with apical aneurysm and
fibrosis consistent with apical scar on delayed enhancement.The patient wasmedically treated and subsequently underwent elective
implantable defibrillator placement in the ensuing months for recurrent nonsustained ventricular tachycardia and was initiated on
prophylactic oral anticoagulation with warfarin for thromboembolic risk reduction.
1. Introduction
Hypertrophic cardiomyopathy (HCM) is an inherited dis-
order of the cardiac muscle and is well known as the most
common cause of sudden cardiac death in individuals less
than 35 years of age in North America. It is an autosomal
dominant condition with reported prevalence of 1 in 500.
HCM is caused by a genetic defect which results in the
mutation of the sarcomere or its associated proteins resulting
in dysfunction of the myocardium. Most HCM patients
(90%) are diagnosed with asymmetric septal hypertrophy,
with the less common variations being midventricular/apical
(1%) and posteroseptal and isolated lateral wall hypertrophy
(1%). Although only 25–35% of the patients demonstrate
obstruction at rest, provocable gradients can be demonstrated
in up to 75% of HCM patients [1].
Pathophysiology of HCM includes left ventricular out-
flow tract obstruction, diastolic dysfunction, myocardial
ischemia, autonomic dysfunction, and mitral valve regurgi-
tation [2].
We present a case where initial diagnosis of apical
ballooning (Takotsubo cardiomyopathy) was suspected at
coronary angiography, but subsequent multimodality imag-
ing with echocardiography and magnetic resonance estab-
lished the unique entity of midventricular HCM with apical
aneurysm.
2. Case Report
A 75-year-old African American female with stage 4 chronic
kidney disease presentedwith a 3-day history of atypical chest
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Figure 1: 12-lead electrocardiogram.
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Figure 2: Left ventriculogram demonstrating midventricular obstruction with large aneurysmal apical pouch (diastole and systole).
pain and dyspnea. She had a long standing history of hyper-
tension. At presentation, she was hypertensive with blood
pressure of 180/100mmHg. The electrocardiogram ordered
showed sinus rhythm (heart rate: 85 beats/min), ST depres-
sion, and deep Twave abnormality (Figure 1). Initial troponin
I level was 1.5 ng/mL, and she was diagnosed with non-
ST segment elevation myocardial infarction. She was started
on aspirin, clopidogrel, heparin, and beta-blockers and
underwent coronary angiography. The angiogram showed
nonobstructive mild coronary artery disease.
Left ventriculogram was done and showed a hyperdy-
namic midportion of the ventricle with a large aneurysmal
dyskinetic sac with stasis of contrast (Figures 2(a) and 2(b)).
Given her acute coronary syndrome-like presentation, it was
suspected that she had possible Takotsubo cardiomyopathy
(apical ballooning) and was admitted for further evalua-
tion.
She underwent transthoracic echocardiogram the next
day, and the noncontrast image shown in Figure 3(a)
displayed moderate left ventricular hypertrophy including
asymmetric septal hypertrophy but poor visualization of the
apex and no definite dyskinetic cavity as shown on the left
ventricular angiogram. However, to define the apex better,
echocardiographic contrast was utilized and the contrast
images clearly demonstrated midventricular narrowing, a
hyperdynamic zone, and apical aneurysmal zone similar to
coronary angiogram (Figure 3(b)). There was flow acceler-
ation demonstrable with paradoxic Doppler flow between
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Figure 3: (a) Noncontrast transthoracic echocardiographic 4-chamber image demonstrating left ventricular hypertrophy and inability to
visualize apical pouch. (b) Contrast transthoracic echocardiographic image demonstrating midventricular narrowing with aneurysmal apex.
the mid cavity narrowing and the apical aneurysmal zone
(Figure 4).
Based on the constellation of findings, she was diagnosed
with midventricular HCM with apical aneurysm formation.
She underwent cardiac magnetic resonance imaging (MRI)
with gadolinium contrast that confirmed the diagnosis and
further illustrated concomitant outflow tract obstruction
and significant septal hypertrophy with moderate to severe
secondary mitral regurgitation (Figures 5(a) and 5(b)).
During her hospital course, she had multiple bouts of
nonsustained ventricular tachycardia. She subsequently
underwent implantable cardioverter defibrillator placement
and was initiated on warfarin for stroke prevention.
3. Discussion
This case represents an uncommon variant of HCM, namely,
midventricular obstructive variant with apical aneurysm
formation, which occurs in only 1-2% of HCM patients
[1]. Although a different diagnosis was entertained initially,
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Figure 4: Doppler flow pattern across midventricular obstructive ventricle.
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Figure 5: (a) Cine 4-chamber image of cardiacMRI donewith steady state free precession imaging (SSFP) demonstrating diffuse hypertrophy
with aneurysmal apex. (b) Delayed enhancement 4-chamber MRI image demonstrating thinned apex and apical scarring.
strengths of multimodality imaging performed appropriately
in this case clinched the final diagnosis and significantly
impacted patient management.
The pathophysiology of apical aneurysm formation is
fascinating. The midventricular variant of HCM involves
hypertrophy of the midventricle, which can be exacerbated
by hypertension. The hypertrophy creates 2 adjacent cavities
on either side of the obstruction during systole.The proximal
cavity develops a low pressure zone and the distal cavity
forms a high pressure zone leading to necrosis due to chronic
subendocardial ischemia.This subsequently leads to scarring,
thinning, and apical aneurysm formation in the infarcted
tissue [1].
Apical aneurysm formation and the decrease in cardiac
output are attributed to a higher risk of small vessel dis-
ease and increase the chances for sudden cardiac arrest or
acute myocardial infarction from ventricular arrythmias and
thrombus formation due to stasis of blood [3, 4].
Of note, noncontrast echocardiography did not correctly
delineate this apical aneurysmal zone well. It is well known
that foreshortening of the apex is a limitation of transthoracic
echocardiograms. However, the addition of contrast imaging
highlighted the apical dyssynergic zone very well. Unique
Doppler patterns first described in midventricular HCM by
Nakamura et al. (paradoxic jet flow) were also noted in our
patient with Doppler echocardiography [5]. These unique
Doppler flow patterns are often the clue towards concealed
apical asynergy/dyssynergy, as was seen in our case.The para-
doxic jet flow is from the apex to the base and is likely related
to higher diastolic pressure at the apex moving blood to the
lower pressure proximal zone, and in the original description
by Nakamura et al., it was observed in 20/198 patients with
midventricular HCM. Interestingly, such patients were found
to have higher incidence of systemic embolism, ventric-
ular arrhythmias, and thallium perfusion defects in their
study. It is possible that persistent high diastolic pressure
Case Reports in Cardiology 5
compromises subendocardial perfusion and contributes to
apical necrosis and the development of aneurysmal deforma-
tion. Importantly, as Doppler is independent of image quality,
such unique Doppler patterns can alert clinicians of apical
pouch/midventricular obstructive physiology.
Cardiac MRI carries unique value in the workup of HCM
as it helps to detect more atypical variants of HCM such
as apical HCM and anterolateral wall variant HCM, which
seems to be underrecognized by echocardiography due to
limitations in adequately imaging these areas.
Cardiac MRI is also recommended as an adjunctive test
by the 2011 guidelines for evaluating the anatomy when the
decision regarding septal ablation versus myectomy is not
clear [2]. Mitral valve morphologic variations, anomalous
location of papillary muscles, multiple papillary muscle
heads, and myocardial crypts are numerous additional find-
ings that can be better demonstrated by cardiac MRI. More
recently, cardiac MRI with delayed enhancement imaging
with gadolinium has been shown to have increasing prognos-
tic value with regard to assessment of myocardial scarring,
which is noted in a majority of patients with HCM. In
our patient, myocardial scarring was demonstrated in the
infarcted apical zone, and such areas increase the risk for
ventricular arrhythmias. Recent data suggest that the extent
of scarring demonstrated on cardiac MRI greater than or
equal to 15% of the total myocardiummay be associated with
an increased risk of cardiac events in HCM patients [6].
Treatment ofmidventricular HCM is targeted at reducing
the symptoms, such as the intraventricular gradient, and the
risk of complications, such as heart failure and sudden cardiac
death. Beta-blockers and calcium blockers can contribute to
reduction of obstructive gradients with negative inotropic
effect, decreasing outflow obstruction and restoring cardiac
output [2]. Septal myectomy, through resection of a portion
of the septum, can achieve a similar effect by widening the
outflow tract if concomitant outflow obstruction is present
but may not be applicable to the midventricular variant
[1].
For patients with midventricular HCM and apical
aneurysm, treatment options are controversial. Relief of
obstruction at the mid- and basal ventricle follows standard
recommendations as in the guidelines for HCM [2, 7], but
this subset of patients is at a higher risk for ventricular
arrhythmias and has been identified as one of the anatomic
substrates in decision-making towards a primary prevention
implantable cardioverter defibrillator (ICD). Anticoagulants
are not normally given to patients with traditional HCM
unless concomitant atrial fibrillation is noted; however, the
midventricular HCM with apical aneurysm variant may
represent a higher risk variant due to apical stasis of the
blood and high risk of thrombus formation and resulting
embolization and warrant anticoagulation [2].
4. Conclusion
This report outlines a clinical presentation of obstructive
midventricular HCM with apical aneurysm formation as
identified by multimodality imaging. Clinicians should be
aware of the manifestations of this entity to avoid misdiagno-
sis or underdiagnosis, to use multimodality imaging appro-
priately to delineate the anatomic substrate, to recognize the
challenges in management of these patients, and to consider
prophylactic anticoagulation and implantable cardioverter
defibrillator placement to decrease adverse cardiac events in
this subset.
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